The DOI matches its Crossref record; 1,227 of the 1,227 references it cites were found in a registry or an index.
Dopamine, Immunity, and Disease
Open accessAbstract
The neurotransmitter dopamine is a key factor in central nervous system (CNS) function, regulating many processes including reward, movement, and cognition. Dopamine also regulates critical functions in peripheral organs, such as blood pressure, renal activity, and intestinal motility. Beyond these functions, a growing body of evidence indicates that dopamine is an important immunoregulatory factor. Most types of immune cells express dopamine receptors and other dopaminergic proteins, and many immune cells take up, produce, store, and/or release dopamine, suggesting that dopaminergic immunomodulation is important for immune function. Targeting these pathways could be a promising avenue for the treatment of inflammation and disease, but despite increasing research in this area, data on the specific effects of dopamine on many immune cells and disease processes remain inconsistent and poorly understood. Therefore, this review integrates the current knowledge of the role of dopamine in immune cell function and inflammatory signaling across systems. We also discuss the current understanding of dopaminergic regulation of immune signaling in the CNS and peripheral tissues, highlighting the role of dopaminergic immunomodulation in diseases such as Parkinson's disease, several neuropsychiatric conditions, neurologic human immunodeficiency virus, inflammatory bowel disease, rheumatoid arthritis, and others. Careful consideration is given to the influence of experimental design on results, and we note a number of areas in need of further research. Overall, this review integrates our knowledge of dopaminergic immunology at the cellular, tissue, and disease level and prompts the development of therapeutics and strategies targeted toward ameliorating disease through dopaminergic regulation of immunity. SIGNIFICANCE STATEMENT: Canonically, dopamine is recognized as a neurotransmitter involved in the regulation of movement, cognition, and reward. However, dopamine also acts as an immune modulator in the central nervous system and periphery. This review comprehensively assesses the current knowledge of dopaminergic immunomodulation and the role of dopamine in disease pathogenesis at the cellular and tissue level. This will provide broad access to this information across fields, identify areas in need of further investigation, and drive the development of dopaminergic therapeutic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 1,001–1,200 of 1,227
Nayak, S. U., Cicalese, S. M., Tallarida, C., Oliver, C. F., & Rawls, S. M. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.09.017 · Cited by 40
Methamphetamine and Cannabis: A Tale of Two Drugs and their Effects on HIV, Brain, and Behavior
Saloner, R., Fields, J. A., Marcondes, M. C. G., Iudicello, J. E., von Känel, S., Cherner, M., Letendre, S. L., Kaul, M., & Grant, I. (2020) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-020-09957-0 · Cited by 40
Dopamine receptor subtypes in the native human heart
Cavallotti, C. A. P., Mancone, M., Bruzzone, P., Sabbatini, M., & Mignini, F. (2010) · Heart and Vessels · doi:10.1007/s00380-009-1224-4 · Cited by 39
de Melo, G. E. B. A., Nicolato, R., de Oliveira, A. C. P., Menezes, G. B., Lelis, F., Sathler-Avelar, R., Sá, J., Bauer, M. E., Souza, B. R., Teixeira, A. L., et al. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.03.004 · Cited by 39
Review Paper: Role of Nitric Oxide on Dopamine Release and Morphine-Dependency
Motahari, A. A., Sahraei, H., & Meftahi, G. H. (2016) · Basic and Clinical Neuroscience Journal · doi:10.15412/j.bcn.03070401 · Cited by 39
Carlson, S. W., & Dixon, C. E. (2018) · Journal of Neurotrauma · doi:10.1089/neu.2017.5509 · Cited by 39
Basova, L., Najera, J. A., Bortell, N., Wang, D., Moya, R., Lindsey, A., Semenova, S., Ellis, R. J., & Marcondes, M. C. G. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199861 · Cited by 39
Hasbi, A., Sivasubramanian, M., Milenkovic, M., Komarek, K., Madras, B. K., & George, S. R. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105017 · Cited by 39
Ugalde, V., Contreras, F., Prado, C., Chovar, O., Espinoza, A., & Pacheco, R. (2021) · Mucosal Immunology · doi:10.1038/s41385-020-00354-7 · Cited by 39
Mikulak, J., Bozzo, L., Roberto, A., Pontarini, E., Tentorio, P., Hudspeth, K., Lugli, E., & Mavilio, D. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401114 · Cited by 38
Lee, L.-T., Tsai, H. C., Chi, M. H., Chang, W. H., Chen, K. C., Lee, I. H., Chen, P. S., Yao, W. J., Chiu, N.-T., & Yang, Y. K. (2015) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000067 · Cited by 38
Vermeulen, R. J., Jongenelen, C. A. M., Langeveld, C. H., Wolters, E. C., Stoof, J. C., & Drukarch, B. (1994) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(94)90034-5 · Cited by 38
Sriram, U., Cenna, J. M., Haldar, B., Fernandes, N. C., Razmpour, R., Fan, S., Ramirez, S. H., & Potula, R. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.4a0814-395rr · Cited by 38
Kim, A., Nigmatullina, R. R., Zalyalova, Z. A., Soshnikova, N. V., Краснов, А. Н., Vorobyeva, N. E., Georgieva, S. G., Кудрин, В. С., Наркевич, В. Б., & Ugrumov, M. V. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1315-2 · Cited by 38
Fanni, S., Scheggi, S., Rossi, F., Tronci, E., Traccis, F., Stancampiano, R., Montis, M. G. D., Devoto, P., Gambarana, C., Bortolato, M., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.09.018 · Cited by 38
Vinpocetine regulates levels of circulating TLRs in Parkinson’s disease patients
Ping, Z., Wu, X., Xufang, X., & Shao, L. (2018) · Neurological Sciences · doi:10.1007/s10072-018-3592-y · Cited by 38
Wang, M., Wang, C., Zhang, Y., & Lin, Y. (2021) · Materials Science and Engineering C · doi:10.1016/j.msec.2021.112376 · Cited by 38
Elevated Brain Monoamine Oxidase Activity in SIV- and HIV-associated Neurological Disease
Meulendyke, K. A., Ubaida‐Mohien, C., Drewes, J. L., Liao, Z., Gama, L., Witwer, K. W., Graham, D. R. M., & Zink, M. C. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu194 · Cited by 37
Figueroa, C. A., Gálvez‐Cancino, F., Oyarce, C., Contreras, F., Prado, C. E., Valeria, C., Cruz, S. R., Lladser, Á., & Pacheco, R. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.12.014 · Cited by 37
Risk of developing psoriasis in patients with schizophrenia: a nationwide retrospective cohort study
Yu, S., Yu, C.-L., Huang, Y., Tu, H., & Lan, C.-C. E. (2017) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14303 · Cited by 37
Uddin, S. M. Z., Robison, L. S., Fricke, D., Chernoff, E., Hadjiargyrou, M., Thanos, P. K., & Komatsu, D. E. (2018) · Scientific Reports · doi:10.1038/s41598-018-19894-x · Cited by 37
Findling, R. L., Adler, L. A., Spencer, T. J., GOLDMAN, R. S., Hopkins, S. C., Koblan, K. S., KENT, J. M., Hsu, J., & Loebel, A. D. (2019) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2018.0083 · Cited by 37
HIV-Associated Apathy/Depression and Neurocognitive Impairments Reflect Persistent Dopamine Deficits
McLaurin, K. A., Harris, M., Madormo, V. A., Harrod, S. B., Mactutus, C. F., & Booze, R. M. (2021) · Cells · doi:10.3390/cells10082158 · Cited by 37
Carvalho-Freitas, M. I. R., Rodrigues-Costa, E. C., Nasello, A. G., Palermo‐Neto, J., & Felício, L. F. (2008) · NeuroImmunoModulation · doi:10.1159/000148196 · Cited by 36
Laatikainen, L. M., Sharp, T., Bannerman, D. M., Harrison, P. J., & Tunbridge, E. M. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112454228 · Cited by 36
Ruffolo, R. R., Jr., Messick, K., & Horng, J. S. (1984) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00501436 · Cited by 36
Renoprotective effect of a dopamine D3 receptor antagonist in experimental type II diabetes
Gross, M., Koch, A., Mühlbauer, B., et al. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700383 · Cited by 36
Seizure promotion by D1 agonists does not correlate with other dopaminergic properties
Starr, M. S., & Starr, B. S. (1993) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02252620 · Cited by 36
Dopamine D2receptors' effects on renal inflammation are mediated by regulation of PP2A function
Zhang, Y., Jiang, X., Qin, C., Cuevas, S., José, P. A., & Armando, I. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00453.2014 · Cited by 36
Eldrup, E. (2004) · PubMed · Cited by 36
Dopamine directly increases mitochondrial mass and thermogenesis in brown adipocytes
Kohlie, R., Perwitz, N., Resch, J., Schmid, S. M., Lehnert, H., Klein, J. C., & Iwen, K. A. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0159 · Cited by 36
Regulation of glomerulotubular balance: flow-activated proximal tubule function
Wang, T., Weinbaum, S., & Weinstein, A. M. (2017) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-017-1960-8 · Cited by 36
Dopamine induces functional extracellular traps in microglia
Agrawal, I., Sharma, N., Saxena, S., Arvind, S., Chakraborty, D., Chakraborty, D. B., Jha, D. K., Ghatak, S., Epari, S., Gupta, T., et al. (2021) · iScience · doi:10.1016/j.isci.2020.101968 · Cited by 36
Roman-Urrestarazu, A., Lindholm, P., Moilanen, I., Kiviniemi, V., Miettunen, J., Jääskeläinen, E., Mäki, P., Hurtig, T., Ebeling, H., Barnett, J. H., et al. (2016) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-015-0755-8 · Cited by 35
Takeuchi, Y., & Fukunaga, K. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01711.x · Cited by 35
Receptor mechanisms of antipsychotic drug action in bipolar disorder – focus on asenapine
Reynolds, G. P. (2011) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125311430112 · Cited by 35
Suppressive effect of berberine on experimental dextran sulfate sodium-induced colitis
Hong, T., Yang, Z. F., Lv, C.-F., & Zhang, Y. (2012) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2011.609887 · Cited by 35
the German Competence Network HIV/AIDS, Horn, A., Scheller, C., du Plessis, S., Arendt, G., Nolting, T., Joska, J. A., Sopper, S., Maschke, M., Obermann, M., et al. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-013-1086-x · Cited by 35
Acharjee, S., Branton, W. G., Vivithanaporn, P., Maingat, F. G., Paul, A. M., Dickie, P., Baker, G. B., & Power, C. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.02.016 · Cited by 35
Tong, R., Wei, C., Pan, L., & Zhang, X. (2019) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2019.103473 · Cited by 35
Nickoloff-Bybel, E. A., Mackie, P. M., Runner, K., Matt, S. M., Khoshbouei, H., & Gaskill, P. J. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.08.191 · Cited by 35
Self-citationThe Role of the Renal Dopaminergic System and Oxidative Stress in the Pathogenesis of Hypertension
Qaddumi, W. N., & José, P. A. (2021) · Biomedicines · doi:10.3390/biomedicines9020139 · Cited by 35
Lin, M., Zhang, B., Shen, N., Dong, X., Zhang, C., Qi, X., Zhu, J., Li, Y.-Z., Man, M., & Tu, C. (2014) · European Journal of Dermatology · doi:10.1684/ejd.2014.2436 · Cited by 34
Clinckers, R., Gheuens, S., Smolders, I. J., Meurs, A., Ebinger, G., & Michotte, Y. M. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.57004.x · Cited by 34
Atypical Neuroleptic Drugs Downregulate Dopamine Sensitivity in Rat Cortical and Striatal Astrocytes
Reuß, B., & Unsicker, K. (2001) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2001.1017 · Cited by 34
Pan, Z., Rosenblat, J. D., Swardfager, W., & McIntyre, R. S. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612823666170111144340 · Cited by 34
The role of human dopamine transporter in NeuroAIDS
Zhu, J., Ananthan, S., & Zhan, C. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.10.007 · Cited by 34
Dopamine release, diffusion and uptake: A computational model for synaptic and volume transmission
Wiencke, K., Horstmann, A., Mathar, D., Villringer, A., & Neumann, J. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008410 · Cited by 34
Antibasal Ganglia Antibodies and Antistreptolysin O in Noncomorbid ADHD
Toto, M., Margari, F., Simone, M., Craig, F., Petruzzelli, M. G., Tafuri, S., & Margari, L. (2012) · Journal of Attention Disorders · doi:10.1177/1087054712455505 · Cited by 33
Profile of Chicken Macrophage Functions After Exposure to CatecholaminesIn Vitro
Ali, R. A., Qureshi, M. A., & McCorkle, F. M. (1994) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923979409019742 · Cited by 33
Anlauf, M., Schäfer, M. K.-H., Schwark, T., von Wurmb‐Schwark, N., Brand, V., Sipos, B., Horny, H., Parwaresch, R. M., Hartschuh, W., Eiden, L. E., et al. (2005) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.5a6739.2005 · Cited by 33
Johnson, T., Tulis, D. A., Keeler, B. E., Virag, J. A. I., Lust, R. M., & Clemens, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074116 · Cited by 33
Andrianarivelo, A., Saint‐Jour, E., Pousinha, P. A., Fernández, S. P., Petitbon, A., Smedt, V. D., Heck, N., Ortiz, V., Allichon, M., Kappès, V., et al. (2021) · Science Advances · doi:10.1126/sciadv.abg5970 · Cited by 33
Wang, X., Luo, H., Chen, C., Chen, K., Wang, J., Cai, Y., Zheng, S., Yang, X., Zhou, L., José, P. A., et al. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.08.010 · Cited by 32
Renal dopamine and angiotensin II receptor signaling in age-related hypertension
Chugh, G., Pokkunuri, I. D., & Asghar, M. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00441.2012 · Cited by 32
Dobson, R., Yarnall, A. J., Noyce, A. J., & Giovannoni, G. (2013) · Practical Neurology · doi:10.1136/practneurol-2012-000435 · Cited by 32
Pereira, A., McLaren, A., Bell, W. R., Copolov, D., & Dean, B. (2003) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500179 · Cited by 32
Kuric, E., & Ruscher, K. (2014) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0145-z · Cited by 32
Reduced D2/D3 Receptor Binding of Extrastriatal and Striatal Regions in Temporal Lobe Epilepsy
Bernedo, V., Buchholz, H., Gartenschläger, M., Breimhorst, M., Schreckenberger, M., & Werhahn, K. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141098 · Cited by 32
Measurement of catecholamines in mouse bone marrow by means of HPLC with electrochemical detection.
Marino, F., Cosentino, M., Bombelli, R., Ferrari, M., Maestroni, G. J. M., Conti, A. M. F., Lecchini, S., & Frigo, G. M. (1997) · PubMed · Cited by 32
Dopamine inhibits human CD8+ Treg function through D1-like dopaminergic receptors
Nasi, G., Ahmed, T., Rasini, E., Fenoglio, D., Marino, F., Filaci, G., & Cosentino, M. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.02.007 · Cited by 32
Jones-Tabah, J., Mohammad, H., Hadj-Youssef, S., Kim, L., Martin, R., Benaliouad, F., Tanny, J. C., Clarke, P. B. S., & Hébert, T. E. (2020) · Scientific Reports · doi:10.1038/s41598-020-71121-8 · Cited by 32
Freund, N., Thompson, B. S., Sonntag, K., Meda, S., & Andersen, S. L. (2016) · Psychopharmacology · doi:10.1007/s00213-015-4200-y · Cited by 31
Clonidine Reduces Dopamine and Increases GABA in the Nucleus Accumbens
Murai, T., Yoshida, Y., Koide, S., Takada, K., Misaki, T., Koshikawa, N., & Cools, A. R. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00050-1 · Cited by 31
Arterial Blood Pressure and Renal Sodium Excretion in Dopamine D3 Receptor Knockout Mice
Staudacher, T., Pech, B., Tappe, M., Groß, G., Mühlbauer, B., & Luippold, G. (2007) · Hypertension Research · doi:10.1291/hypres.30.93 · Cited by 31
Shin, Y., Kumar, U., Patel, Y., Patel, S. C., & Sidhu, A. (2003) · Journal of Hypertension · doi:10.1097/00004872-200301000-00030 · Cited by 31
Saika, F., Kiguchi, N., Wakida, N., Kobayashi, D., Fukazawa, Y., Matsuzaki, S., & Kishioka, S. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.11.042 · Cited by 31
Dopamine D2 receptor upregulates leptin and IL-6 in adipocytes
Wang, X., Villar, V. A. M., Tiu, A. C., Upadhyay, K. K., & Cuevas, S. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m081000 · Cited by 31
Altered gastric tone and motility response to brain-stem dopamine in a rat model of parkinsonism
Bove, C., Anselmi, L., & Travagli, R. A. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00076.2019 · Cited by 31
Ruso‐Julve, F., Pombero, A., Pilar-Cuéllar, F., García‐Díaz, N., Garcia-Lopez, R., Juncal‐Ruíz, M., Castro, E., Díaz, Á., Vázquez-Bourgón, J., García-Blanco, A., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0647-7 · Cited by 31
Sun, L., Jiang, W.-W., Wang, Y., Yuan, Y.-S., Rong, Z., Wu, J., Fan, Y., Lu, M., & Zhang, K.-Z. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00676-w · Cited by 31
Pituitary dendritic cells communicate immune pathogenic signals
Glennon, E., Kaunzner, U. W., Gagnidze, K., McEwen, B. S., & Bulloch, K. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.07.007 · Cited by 30
Monoamine metabolite levels in CSF of SIV-infected rhesus monkeys (Macaca mulatta)
Koutsilieri, E., Götz, M. E., Sopper, S., et al. (1997) · Neuroreport · doi:10.1097/00001756-199712010-00034 · Cited by 30
Saussez, S., Laumbacher, B., Chantrain, G., Rodriguez, A., Gu, S., Wank, R., & Levite, M. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1242-y · Cited by 30
Glucuronide and sulfate catecholamine conjugates in rat and human plasma
Claustre, J., Sérusclat, P., & Peyrin, L. (1983) · Journal of Neural Transmission · doi:10.1007/bf01243495 · Cited by 30
Evans, S. R., Yeh, T., Sacktor, N. C., Clifford, D. B., Simpson, D. M., Miller, E. N., Ellis, R. J., Valcour, V., Marra, C. M., Millar, L., et al. (2007) · HIV Clinical Trials · doi:10.1310/hct0806-437 · Cited by 30
Faraj, B. A., Olkowski, Z. L., & Jackson, R. T. (2008) · Pharmacology · doi:10.1159/000138790 · Cited by 30
Yoshimura, M., Kambara, S., Okabayashi, H., Takahashi, H., & Ijichi, H. (1987) · Clinical and Experimental Hypertension · doi:10.3109/10641968709160039 · Cited by 30
Zager, A., Brandão, W. N., Margatho, R. O., Peron, J. P. S., Tufik, S., Andersen, M. L., Kornum, B. R., & Palermo‐Neto, J. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.05.003 · Cited by 30
Kegeles, L. S., Horga, G., Ghazzaoui, R., Rosengard, R., Ojeil, N., Xu, X., Slifstein, M., Petrakis, I. L., O’Malley, S. S., Krystal, J. H., et al. (2018) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2018.03.018 · Cited by 30
Chronic oral methylphenidate treatment increases microglial activation in rats
Carias, E., Hamilton, J., Robison, L. S., Delis, F., Eiden, R. D., Quattrin, T., Hadjiargyrou, M., Komatsu, D. E., & Thanos, P. K. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1931-z · Cited by 30
Wang, B., Chen, T., Li, G., Jia, Y., Wang, J., Li, X., & Chen, Y. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02730-7 · Cited by 30
Lipid Rafts and Dopamine Receptor Signaling
Martinez, V. J., Asico, L. D., José, P. A., & Tiu, A. C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238909 · Cited by 30
Alam, S. I., Jo, M. G., Park, T. J., Ullah, R., Ahmad, S., Rehman, S. U., & Kim, M. O. (2021) · Biomedicines · doi:10.3390/biomedicines9010047 · Cited by 30
Functional characterization of the biogenic amine transporters on human macrophages
Mackie, P. M., Gopinath, A., Montas, D. M., Nielsen, A. M., Smith, A. R., Nolan, R. A., Runner, K., Matt, S. M., McNamee, J., Riklan, J. E., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.151892 · Cited by 30
Self-citationLaihinen, A., Rinne, J. O., Ruottinen, H., Någren, K., Lehikoinen, P., Oikonen, V., Ruotsalainen, U., & Rinne, U. K. (1994) · PubMed · Cited by 29
Disruption of the dopamine transporter–dopamine D2 receptor interaction in schizophrenia
Lee, F. J. S., Pei, L., & Liu, F. (2009) · Synapse · doi:10.1002/syn.20648 · Cited by 29
Serotonin syndrome induced by augmentation of SSRI with methylphenidate
Ishii, M., Tatsuzawa, Y., Yoshino, A., & Nomura, S. (2008) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2008.01767.x · Cited by 29
Cui, Y., Prabhu, V. V., Nguyen, T. B., Yadav, B., & Chung, Y. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161125983 · Cited by 29
Park, P. K., Caballero, J., & Omidian, H. (2013) · Annals of Pharmacotherapy · doi:10.1177/1060028013506561 · Cited by 29
Hutchison, M. A., Gu, X., Adrover, M. F., LEE, M. R., Hnasko, T. S., Alvarez, V. A., & Lü, W. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.7 · Cited by 29
Metabolism of Dopamine in Nucleus Accumbens Astrocytes Is Preserved in Aged Mice Exposed to MPTP
Winner, B. M., Zhang, H., McKenzie, M. F., Karchalla, L. M., Lookingland, K. J., & Goudreau, J. L. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00410 · Cited by 29
Dopaminergic Agents in Rheumatoid Arthritis
Capellino, S. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09850-5 · Cited by 29
Yang, L. L., Stiernborg, M., Skott, E., Söderström, Å., Giacobini, M., & Lavebratt, C. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.10.005 · Cited by 29
Cosentino, M., Ferrari, M., Kuštrimović, N. Z., Rasini, E., & Marino, F. (2015) · Human Immunology · doi:10.1016/j.humimm.2015.09.032 · Cited by 28
Barili, P., Bronzetti, E., Felici, L., Ferrante, F., Rícci, A., Zaccheo, D., & Amenta, F. (1996) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00127-0 · Cited by 28
NF-κB activity is inversely correlated to RNF11 expression in Parkinson's disease
Pranski, E. L., Sanford, C. V., Dalal, N. V., Orr, A. L., Karmali, D., Cooper, D. S., Gearing, M., Lah, J. J., Levey, A. I., & Betarbet, R. S. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.04.056 · Cited by 28
Bupropion in adults with Attention-Deficit/Hyperactivity Disorder: a randomized, double-blind study.
Hamedi, M., Mohammdi, M., Ghaleiha, A., Keshavarzi, Z., Jafarnia, M., Keramatfar, R., Alikhani, R., Ehyaii, A., & Akhondzadeh, S. (2014) · PubMed · Cited by 28
Chronic lithium treatment rectifies maladaptive dopamine release in the nucleus accumbens
Can, A., Frost, D. O., Cachope, R., Cheer, J. F., & Gould, T. D. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13769 · Cited by 28
Implications of the new sepsis definition on research and practice
Peach, B. C. (2016) · Journal of Critical Care · doi:10.1016/j.jcrc.2016.11.032 · Cited by 28
Dopaminergic Control of Inflammation and Glycemia in Sepsis and Diabetes
Feketeova, E., Li, Z., Joseph, B., Shah, R., Spolarics, Z., & Ulloa, L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00943 · Cited by 28
Coelho‐Santos, V., Cardoso, F. L., Magalhães, A., Ferreira-Teixeira, M., Leitão, R. A., Gomes, C. M. F., Rito, M., Barbosa, M., Ribeiro, C., & Silva, A. P. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.12.007 · Cited by 28
Ungprasert, P., Wijarnpreecha, K., & Cheungpasitporn, W. (2019) · Journal of Postgraduate Medicine · doi:10.4103/jpgm.jpgm_253_18 · Cited by 28
Osorio‐Barrios, F., Navarro, G., Campos, J., Ugalde, V., Prado, C. E., Raïch, I., Contreras, F., López, E., Espinoza, A., Lladser, Á., et al. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.04.006 · Cited by 28
Yue, S., Wang, T., Yang, Y., Fan, Y., Zhou, L., Li, M., & Fu, F. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107798 · Cited by 28
D1-Dopamine Receptor Availability in First-Episode Neuroleptic Naive Psychosis Patients
Stenkrona, P., Matheson, G. J., Halldin, C., Červenka, S., & Farde, L. (2019) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyz017 · Cited by 27
Role of Serotonin and Dopamine in Psoriasis: A Case-Control Study
Wardhana, M., Windari, M., Puspasari, N., & Suryawati, N. (2019) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2019.267 · Cited by 27
Dopaminergic impact of cART and anti-depressants on HIV neuropathogenesis in older adults
Matt, S. M., & Gaskill, P. J. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146398 · Cited by 27
Self-citationThe role of dopamine receptors in lymphocytes and their changes in schizophrenia
Penedo, M. A., Baltanás, T. R., Pérez-Rodríguez, D., Allen, J., Borrajo, A., Alonso-Crespo, D., Fernández-Pereira, C., Nieto-Araujo, M., Ramos-García, S., Barreiro-Villar, C., et al. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100199 · Cited by 27
Dopamine D1 receptor alleviates doxorubicin-induced cardiac injury by inhibiting NLRP3 inflammasome
Liu, J., Jin, Y., Wang, B., Wang, Y., Zuo, S., & Zhang, J. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.04.098 · Cited by 27
Krause, D., Weidinger, E., Dippel, C., Riedel, M. J., Schwarz, M., Müller, N., & Myint, A.-M. (2013) · PubMed · Cited by 26
Changes in extracellular dopamine during cocaine self‐administration in squirrel monkeys
Kimmel, H. L., Ginsburg, B. C., & Howell, L. L. (2005) · Synapse · doi:10.1002/syn.20135 · Cited by 26
Lee, M. Y., Heo, J. S., & Han, H. J. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20674 · Cited by 26
Jiang, W., Li, M., He, F., Bian, Z. X., Liu, J., He, Q., Wang, X., Sun, T., & Zhu, L. (2016) · Spinal Cord · doi:10.1038/sc.2016.52 · Cited by 26
Role of Sigma-1 Receptor in Cocaine Abuse and Neurodegenerative Disease
Cai, Y. C., Yang, L., Niu, F., Liao, K., & Buch, S. J. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-50174-1_12 · Cited by 26
Endogenously produced catecholamines improve the regulatory function of TLR9-activated B cells
Honke, N., Lowin, T., Opgenoorth, B., Shaabani, N., Lautwein, A., Teijaro, J. R., Schneider, M., & Pongratz, G. (2022) · PLoS Biology · doi:10.1371/journal.pbio.3001513 · Cited by 26
Permeation of Dopamine Sulfate through the Blood-Brain Barrier
Suominen, T., Piepponen, P. T., & Kostiainen, R. K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133904 · Cited by 25
Interleukin-1β stimulates tyrosine hydroxylase activity in the median eminence
Abreu, P. M., Llorente, E., Hernández, M., & González, M. C. (1994) · Neuroreport · doi:10.1097/00001756-199406000-00016 · Cited by 25
Reimann, E., Kingo, K., Karelson, M., Reemann, P., Loite, U., Keermann, M., Abram, K., Vasar, E., Silm, H., & Kõks, S. (2012) · Dermatology · doi:10.1159/000338023 · Cited by 25
Meulendyke, K. A., Pletnikov, M. V., Engle, E. L., Tarwater, P. M., Graham, D. R. M., & Zink, M. C. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9332-1 · Cited by 25
Evidence for a role of a dopamine/5-HT6 receptor interaction in cocaine reinforcement
Valentini, V., Piras, G., Luca, M. A. D., Perra, V., Bordi, F., Borsini, F., Frau, R., & Chiara, G. D. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.08.025 · Cited by 25
Yang, X., Sun, X., Chen, H., Xi, G., Hou, Y., Wu, J., Liu, D., Wang, H., Hou, Y., & Yu, J. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.02.002 · Cited by 25
Kim, T., Song, J., Puspita, L., Valiulahi, P., Shim, J., & Lee, S. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.163 · Cited by 25
Valvassori, S. S., Dal-Pont, G. C., Tonin, P. T., Varela, R. B., Ferreira, C. L., Gava, F. F., Andersen, M. L., Soares, J. C., & Quevedo, J. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.05.009 · Cited by 25
Dopamine–mediated immunomodulation affects choroid plexus function
Castellani, G., Contarini, G., Mereu, M., Albanesi, E., Devroye, C., D’Amore, C., Ferretti, V., Martin, S. D., & Papaleo, F. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.06.006 · Cited by 25
TNFα increases tyrosine hydroxylase expression in human monocytes
Gopinath, A., Badov, M., Francis, M. L., Shaw, G., Collins, A., Miller, D. R., Hansen, C. A., Mackie, P. M., Tansey, M. G., Dagra, A., et al. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-021-00201-x · Cited by 25
Fuenzalida, J., Galaz, P., Araya, K. A., Slater, P. G., Blanco, E. H., Campusano, J. M., Ciruela, F., & Gysling, K. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12868 · Cited by 24
Macrophage Fcγ Receptors Expression Is Altered by Treatment with Dopaminergic Drugs
Gomez, F., Ruiz, P., Briceño, F., Rivera, C., & Lopez, R. (1999) · Clinical Immunology · doi:10.1006/clim.1998.4665 · Cited by 24
Cornil, C. A., Castelino, C. B., & Ball, G. F. (2007) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2007.10.004 · Cited by 24
Fardoun, R. Z., Asghar, M., & Lokhandwala, M. F. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.11.033 · Cited by 24
Catecholamine release in human skin—a microdialysis study
Leis, S., Drenkhahn, S., Schick, C. H., Arnolt, C., Schmelz, M., Birklein, F., & Bickel, A. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.03.013 · Cited by 24
Reduced splenic natural killer cell activity in rats with a hyperreactive dopaminergic system
Teunis, M., Heijnen, C. J., Cools, A. R., & Kavelaars, A. (2003) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2003.09.007 · Cited by 24
Yamamoto, S., Ohta, N., Matsumoto, A., Horiguchi, Y., Koide, M., & Fujino, Y. (2016) · Medical Science Monitor · doi:10.12659/msm.895739 · Cited by 24
Resting-state subcortical functional connectivity in HIV-infected patients on long-term cART
Janssen, M. A. M., Hinne, M., Janssen, R. J., van Gerven, M. A. J., Steens, S. C. A., Goraj, B. M., Koopmans, P. P., & Kessels, R. P. C. (2016) · Brain Imaging and Behavior · doi:10.1007/s11682-016-9632-4 · Cited by 24
Liu, A., & Ding, S. (2019) · PubMed · Cited by 24
Shao, X., Zhang, X., Hu, J. R., Gao, T., Chen, J., Xu, C., & Wei, C. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.111849 · Cited by 24
Cao, J.-Y., Zhou, L., Li, Z., Yang, Y., Liu, B., & Liu, H. (2020) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2020.04.005 · Cited by 24
Recent Findings and Current Status of Augmentation Strategies
Nelson, J. C. (2007) · CNS Spectrums · doi:10.1017/s1092852900016011 · Cited by 23
Seol, I.-W., Kuo, N. Y., & Kim, K. M. (2004) · Archives of Pharmacal Research · doi:10.1007/bf02980053 · Cited by 23
Models of Dopaminergic and Serotonergic Signaling
Best, J. A., Reed, M. C., & Nijhout, H. F. (2010) · Pharmacopsychiatry · doi:10.1055/s-0030-1252024 · Cited by 23
Mocchetti, I., Bachis, A., Campbell, L. A., & Avdoshina, V. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9488-y · Cited by 23
Risk of Parkinson's disease among patients with psoriasis: A systematic review and meta-analysis
Ungprasert, P., Srivali, N., & Kittanamongkolchai, W. (2016) · Indian Journal of Dermatology · doi:10.4103/0019-5154.177771 · Cited by 23
Cutaneous pigmentation modulates skin sensitivity via tyrosinase-dependent dopaminergic signalling
Ono, K., Viet, C. T., Ye, Y., Dang, D., Hitomi, S., Toyono, T., Inenaga, K., Dolan, J. C., & Schmidt, B. L. (2017) · Scientific Reports · doi:10.1038/s41598-017-09682-4 · Cited by 23
Enhanced Cardiac L-Type Calcium Current Response to β2-Adrenergic Stimulation in Heart Failure
Zhang, Z.-S., Cheng, H.-J., Ukai, T., Tachibana, H., & Cheng, C. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29367-8 · Cited by 23
Protection of MPTP-induced neuroinflammation and neurodegeneration by rotigotine-loaded microspheres
Yu, X., Yao, J.-Y., He, J., & Tian, J. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.01.014 · Cited by 22
Zweckberger, K., Šimunović, F., Kiening, K. L., Unterberg, A. W., & Sakowitz, O. W. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2009.12.075 · Cited by 22
Choroid plexus blood flow: evidence for dopaminergic influence
Townsend, J. B., Ziedonis, D. M., Bryan, R. M., Brennan, R. W., & Page, R. B. (1984) · Brain Research · doi:10.1016/0006-8993(84)90748-0 · Cited by 22
Gómez, M. D. J., Rousseau, G., Nadeau, R. A., Berra‐Romani, R., Flores, G., & Suárez, J. (2002) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y02-081 · Cited by 22
Galvão-Lima, L. J., Espíndola, M. S., Soares, L. S., Zambuzi, F. A., Cacemiro, M. D. C., Fontanari, C., Bóllela, V. R., & Frantz, F. G. (2016) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2016.10.004 · Cited by 22
Ali, S. J., Ellur, G., Khan, M. T., & Sharan, K. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.12.003 · Cited by 22
Dopamine Receptor Partial Agonists for the Treatment of Bipolar Disorder
Azorin, J., & Simon, N. (2019) · Drugs · doi:10.1007/s40265-019-01189-8 · Cited by 22
Lipid rafts are required for effective renal D 1 dopamine receptor function
Tiu, A. C., Yang, J., Asico, L. D., Konkalmatt, P. R., Zheng, X., Cuevas, S., Wang, X., Lee, H., Mazhar, M., Felder, R. A., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201902710rr · Cited by 22
Yan, A., Song, L., Zhang, Y., Wang, X., & Liu, Z. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.625166 · Cited by 22
Lee, H., Jiang, X., Perwaiz, I., Yu, P., Wang, J., Wang, Y., Hüttemann, M., Felder, R. A., Sibley, D. R., Polster, B. M., et al. (2021) · Hypertension Research · doi:10.1038/s41440-021-00646-w · Cited by 22
Role of the Extracellular Traps in Central Nervous System
Wu, X., Zeng, H., Cai, L., & Chen, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.783882 · Cited by 22
Bekhbat, M., Ulukaya, G. B., Bhasin, M., Felger, J. C., & Miller, A. H. (2022) · Neurobiology of Stress · doi:10.1016/j.ynstr.2022.100462 · Cited by 22
Huang, C., Wu, J., Liao, R.-J., & Zhang, W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049954 · Cited by 21
Zhu, J., Yuan, Y., Midde, N. M., Gomez, A. M., Sun, W., Quizon, P. M., & Zhan, C. (2015) · Journal of NeuroVirology · doi:10.1007/s13365-015-0391-6 · Cited by 21
Keren, A., Gilhar, A., Ullmann, Y., Frušić‐Zlotkin, M., Soroka, Y., Domb, A. J., & Levite, M. (2019) · Immunology · doi:10.1111/imm.13109 · Cited by 21
Antidepressants in use in clinical practice.
Agius, M. A., & Bonnici, H. (2017) · PubMed · Cited by 21
Dopamine D1 + D3 receptor density may correlate with parkinson disease clinical features
Yang, P., Knight, W. C., Li, H., Guo, Y., Perlmutter, J. S., Benzinger, T. L. S., Morris, J. C., & Xu, J. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51274 · Cited by 21
Marazziti, D., Dell’Osso, M. C., Baroni, S., Másala, I., Dell’Osso, B. M., Consoli, G., Giannaccini, G., Betti, L., & Lucacchini, A. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2009.03.009 · Cited by 20
Analgesic and anti-inflammatory activities of bupropion in animal models.
Hajhashemi, V., & Khanjani, P. (2014) · Europe PMC (PubMed Central) · Cited by 20
Özkan, M., Johnson, N. W., Sehirli, U. S., Woodhall, G. L., & Stanford, I. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181633 · Cited by 20
Mallard, J., & Williams, K. C. (2018) · Journal of NeuroVirology · doi:10.1007/s13365-018-0616-6 · Cited by 20
Bastos, J. D. R., Perico, K. M., Vieira, É. L. M., Teixeira, A. L., Machado, F. S., de Miranda, A. S., & Moreira, F. A. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.04.004 · Cited by 20
Kidney dopamine D 1 -like receptors and angiotensin 1–7 interaction inhibits renal Na + transporters
Banday, A. A., Diaz, A. D., & Lokhandwala, M. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00135.2019 · Cited by 20
Carvalho-Freitas, M. I. R., Anselmo-Franci, J. A., Maiorka, P. C., Palermo‐Neto, J., & Felício, L. F. (2011) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2010.12.008 · Cited by 19
Inflammation compromises renal dopamine D1 receptor function in rats
Asghar, M., Chugh, G., & Lokhandwala, M. F. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00366.2009 · Cited by 19
Micale, V., Incognito, T., Ignoto, A., Rampello, L., Spartà, M., & Drago, F. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.08.003 · Cited by 19
Regulation of neutrophil phagocytosis of Escherichia coli by antipsychotic drugs
Chen, M., Wu, S., Tsai, T., Wang, L.-K., & Tsai, F. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.09.030 · Cited by 19
Matsumoto, A., Ohta, N., Goto, Y., Kashiwa, Y., Yamamoto, S., & Fujino, Y. (2015) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000000606 · Cited by 19
Cosentino, M., Kuštrimović, N. Z., Ferrari, M., Rasini, E., & Marino, F. (2017) · Immunology · doi:10.1111/imm.12843 · Cited by 19
Long-term Use of Clozapine is Protective for Bone Density in Patients with Schizophrenia
Lin, C., Lin, C.-Y., Wang, H.-S., & Lane, H. (2019) · Scientific Reports · doi:10.1038/s41598-019-40691-7 · Cited by 19
D2 dopamine receptor gene (DRD2) Taq1A (rs1800497) affects bone density
Chiang, T.-I., Lane, H., & Lin, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-70262-0 · Cited by 19
Wieber, K., Fleige, L., Tsiami, S., Reinders, J., Braun, J., Baraliakos, X., & Capellino, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-09891-6 · Cited by 19
Brains, Bones, and Aging: Psychotropic Medications and Bone Health Among Older Adults
Brown, M. J., & Mezuk, B. R. (2012) · Current Osteoporosis Reports · doi:10.1007/s11914-012-0121-4 · Cited by 18
Falco, A. M., McDonald, C. G., Bachus, S. E., & Smith, R. F. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.11.007 · Cited by 18
Yoshioka, Y., Sugino, Y., Tozawa, A., Yamamuro, A., Kasai, A., Ishimaru, Y., & Maeda, S. (2016) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2015.11.002 · Cited by 18
Sex-specific factors for bone density in patients with schizophrenia
Lin, C., Lin, C.-Y., Huang, T.-L., Wang, H.-S., Chang, Y., & Lane, H. (2015) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000062 · Cited by 18
Li, X., Geng, Y., Li, M., Jin, Y., Ren, H., Li, X., Wu, F., Wang, B., Cheng, W., Chen, T., et al. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.04.030 · Cited by 18
Lei, W., Sun, Y., Kong, X., Zhang, C., Yue, T., Zhu, Q., He, D., & Jiang, L.-D. (2016) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-016-1220-7 · Cited by 18
Temu, T. M., Zifodya, J. S., Polyak, S. J., Wagoner, J., Wanjalla, C. N., Masyuko, S. J., Nyabiage, J., Kinuthia, J., Bloomfield, G. S., Page, S. T., et al. (2020) · AIDS · doi:10.1097/qad.0000000000002729 · Cited by 18
Fluoxetine Potentiates Oral Methylphenidate-Induced Gene Regulation in the Rat Striatum
Moon, C., Marion, M., Thanos, P. K., & Steiner, H. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02466-y · Cited by 18
Marino, F., Pinoli, M., Rasini, E., Martini, S. D., Luini, A., Pulze, L., Gasperina, D. D., Grossi, P., Legnaro, M., Ferrari, M., et al. (2022) · Immunology · doi:10.1111/imm.13550 · Cited by 18
Dopamine stimulates 45Ca2+ uptake through cAMP, PLC/PKC, and MAPKs in renal proximal tubule cells
Han, J. Y., Heo, J. S., Lee, Y. J., Lee, J., Taub, M. L., & Han, H. J. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20956 · Cited by 17
Mannaioni, P. F., Mastroianni, R., & Mastrangelo, D. (2010) · PubMed · Cited by 17
Parrado, A. C., Salaverry, L. S., Mangone, F. M., Apicella, C., Gentile, T., Canellada, A. M., & Rey-Roldán, E. B. (2017) · NeuroImmunoModulation · doi:10.1159/000486241 · Cited by 17
Won, S. J., Chuang, Y. C., Huang, W. T., Liu, H., & Lin, M. T. (1995) · Cellular and Molecular Life Sciences · doi:10.1007/bf01928892 · Cited by 16
Li, X., Li, X., Chen, Q., He, J., Dong, Y., Wang, J., Shen, S., Jia, R., Zang, Q. J., Zhang, T., et al. (2018) · Clinical Rheumatology · doi:10.1007/s10067-018-4168-1 · Cited by 16
Schneider, E., Machavoine, F., Rignault‐Bricard, R., Levasseur, M., Petit-Bertron, A.-F., Gautron, S., Ribeil, J., Launay, J., Mécheri, S., Côté, F., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.04.043 · Cited by 15
Renal effect of YM435, a new dopamine D1 receptor agonist, in anesthetized dogs
Yatsu, T., Arai, Y., Takizawa, K., Kasai-Nakagawa, C., Takanashi, M., Uchida, W., Inagaki, O., Tanaka, A., Asano, M., Honda, K., et al. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00980-6 · Cited by 15
Collis, L. P., Srivastava, S., Coetzee, W. A., & Artman, M. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00101.2007 · Cited by 15
Matt, S. M., Nickoloff-Bybel, E. A., Rong, Y., Runner, K., Johnson, H. S., O'Connor, M. H., Haddad, E. K., & Gaskill, P. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.663061 · Cited by 15
Self-citationRegulation of Sodium Transport by Endogenous Dopamine Production in Proximal Tubular and OK Cells
Baines, A. D., & Drangova, R. (1997) · Clinical and Experimental Hypertension · doi:10.3109/10641969709080806 · Cited by 14
Casas, R., Muthusamy, S., Wakim, P., Sinharay, S., Lentz, M. R., Reid, W. C., & Hammoud, D. A. (2017) · NeuroImage Clinical · doi:10.1016/j.nicl.2017.11.018 · Cited by 13
A colon-specific prodrug of metoclopramide ameliorates colitis in an experimental rat model
Yang, Y., Kim, W., Kim, D., Jeong, S., Yoo, J., & Jung, Y. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s185257 · Cited by 13
Catelas, D. N., Serrão, P., & Soares-da-Silva, P. (2019) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2019.1583245 · Cited by 13
Ugalde, C. L., Gordon, S. E., Shambrook, M., Kenari, A. N., Coleman, B. M., Perugini, M. A., Lawson, V., Finkelstein, D. I., & Hill, A. F. (2020) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12034 · Cited by 13
Brakedal, B., Tzoulis, C., Tysnes, O., & Haugarvoll, K. (2021) · PLoS ONE · doi:10.1371/journal.pone.0256602 · Cited by 13
Cited by
Uncovering the metabolic impact of acute psychological stress in young adults
Frempong, G. A., Goni, G., Lorenzo-Tejedor, M., De la Cámara, C., Lázaro, J., Mangialavori Rasia, E., Aguiló, J., Bailon, R., & Bernal, M. L. (2026) · Scientific Reports · doi:10.1038/s41598-025-29572-4 · Cited by 3
Metadata
- Authors
- Channer, B., Matt, S. M., Nickoloff-Bybel, E. A., Pappa, V., Agarwal, Y., Wickman, J., & Gaskill, P. J.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2023-01
- Volume
- 75
- Issue
- 1
- Pages
- 62-158
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W4311937162
- Cited by
- 308
- References
- 1,227
- FWCI
- 13.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.